The Nigeria Centre for Disease Control (NCDC) continues to build workforce capacity, as an integral aspect towards efficient and effective delivery of its mandate of protecting the health of Nigerians. As a key initiative under the NCDC strategic plan, the NCDC Leadership and Management Development (LMD) programme was launched in 2018. The aim of the programme is to ensure improved organisational work processes by creating alignment between individual development needs and the NCDC institutional requirements.
Last week in Abuja, NCDC kicked off the first phase of a 3-month Executive Leadership Development Programme; a customised Leadership and Management Development (LMD) programme designed for top management (DG and Directors) facilitated by the Lagos Business School and OutsideIn HR. These leadership and management skills are soft skills that complement technical skills needed for NCDC staff to deliver their functions. Till date, over 50 staff of NCDC have been trained under the different tiers of the LMD programme.
During the four-day training, the NCDC DG and Directors worked together to explore the core competencies of boldness, courage and valuing differences in the workplace. A key outcome was for them to develop a better insight into their leadership style, how it is perceived by others and how it affects their team and overall work performance. A core component of the course was to undergo a personality profile which goal was to highlight and enable them build on their strengths and work on their perceived weaknesses. An essential requirement of the training is the completion of a capstone course and an experiential study tour.
In view of the increasing scope and portfolio of NCDC, it is anticipated that in addition to fostering overall coordination of its work processes, the training will also improve and strengthen the capacity and capability of NCDC leadership to better perform its mandate of protecting the health of Nigerians.
SUMMARY OF REPORTS
In the reporting week ending February 10, 2019:
o There were 122 new cases of Acute Flaccid Paralysis (AFP) reported. None was confirmed as polio. The last reported case of polio in Nigeria was in August 2016. Active case search for AFP is being intensified with the goal to eliminate polio in Nigeria
o There were 14 suspected cases of cholera reported from two LGAs in Kano State. There was no laboratory confirmed case and no death recorded.
o There were 220 suspected cases of Lassa fever reported from 35 LGAs in 18 States (Edo – 70, Ebonyi – 27, Ondo – 41, Bauchi -13, Plateau – 11, Adamawa – 4, Ekiti – 1, Nasarawa – 4, Rivers – 6, FCT – 5, Gombe – 4, Kaduna – 10, Kogi – 1, Enugu – 9, Delta – 7, Benue – 1, Taraba – 16, Delta – 1, Oyo – 3 & Kebbi - 2). 37 were laboratory confirmed and ten deaths were recorded.
o There were 21 suspected cases of Cerebrospinal Meningitis (CSM) reported from 14 LGAs in nine States (Ebonyi – 1, Gombe – 1, Kaduna – 2, Katsina – 4, Kebbi – 6, Ondo – 2, Sokoto – 1, Taraba - 1 & Zamfara – 3). Of these, one was laboratory confirmed and one death was recorded.
o There were 1104 suspected cases of measles reported from 34 States. Nine were laboratory confirmed and two deaths were recorded.
In the reporting week, all States sent in their reports except Benue State. Timeliness of reporting decreased from 94.0% in week five to 93.0% in week six while completeness remained 100.0% at the same period. It is very important for all States to ensure timely and complete reporting at all times, especially during an outbreak.
REPORT ANALYSIS AND INTERPRETATION
1.1 As at February 10 2019, no new case of WPV was recorded
1.2 In the reporting week, 122 suspected cases of AFP were reported from 113 LGAs in 32 States and FCT
1.3 Between week 1 and 6 (2019), 671 suspected cases of AFP were reported from 388 LGAs in 36 states and FCT
2. CEREBROSPINAL MENINGITIS (CSM)
2.1 In the reporting week, 21 suspected Cerebrospinal Meningitis (CSM) cases with one laboratory confirmed and one death (CFR, 4.8%) were reported from 14 LGAs in nine States(Ebonyi – 1, Gombe – 1, Kaduna – 2, Katsina – 4, Kebbi – 6, Ondo – 2, Sokoto – 1, Taraba - 1 & Zamfara – 3) compared with 87 suspected cases and three deaths (CFR, 3.4%) reported across 41 LGAs (16 States) at the same period in 2018 (Figure 1)
2.2 Between weeks 1 and 6 (2019), 173 suspected meningitis cases with nine laboratory confirmed and eight deaths (CFR, 4.62%) from 75 LGAs (20 States) were reported compared with 557 suspected cases with 71 Laboratory confirmed and 37 deaths (CFR, 6.64%) from 122 LGAs in 24 states during the same period in 2018
2.3 Timeliness/completeness of CSM case-reporting from states to the national level (2019 versus 2018): on average, 92.8% of the 26 endemic States sent CSM reports in a timely manner while 99.5% were complete in week 1 - 6, 2019 as against 81.1% timeliness and 100.0% completeness recorded within the same period in 2018
2.4 The CSM National Emergency Operations Centre (EOC) is on alert mode and meets weekly to review the situation
2.5 CSM preparedness and response assessment checklist form sent to all States
3.1 14 suspected cases of cholera were reported from two LGAs (Kano state) in week 6, 2019 compared with 12 suspected cases reported from five LGAs in three States during the same period in 2018 (Figure 2).
3.2 Between weeks 1 and 6 (2019), 78 suspected cholera cases with one laboratory confirmed and six deaths (CFR, 7.69%) from nine LGAs (six States) were reported compared with 689 suspected cases and 32 deaths (CFR, 4.64%) from 43 LGAs in 12 States during the same period in 2018.
3.3 NCDC has disseminated cholera alert mails and line list template to all states in preparedness for dry season transmission
3.4 The cholera National Emergency Operations Centre (EOC) is on watch mode and the Technical Working Group meets weekly to review the situation
3.5 NPHCDA and NCDC conducted training on Oral Cholera Vaccine on February 22, 2019 in Abuja
3.6 National Preparedness and Response to Acute Watery Diarrhoea/Cholera Guidelines. Available from
4 LASSA FEVER
4.1 In the reporting Week 6 (4 – 10 February, 2019), thirty-seven new confirmed I cases were reported from Edo (10), Ondo (12), Ebonyi (4), Plateau (4), Taraba (3), Benue (1), Gombe (1), Rivers (1) and Kebbi (1) States with ten new deaths in Edo (2), Ondo (2), Ebonyi (4) and Plateau (2) States.
4.2 From 1st January – 10th February 2019, a total of 947 suspectedi cases have been reported from 20 States. Of these, 324 were confirmed positive, 3 probable and 620 negatives (not a case)
4.3 Since the onset of the 2019 outbreak, there have been 67 deaths among confirmed cases. Case Fatality Rate in confirmed cases is 21.3%
4.4 Twenty states have recorded at least one confirmed case across 54 LGAs (Edo, Ondo, Bauchi, Nasarawa, Ebonyi, Plateau, Taraba, FCT, Adamawa, Gombe, Kaduna, Kwara, Benue, Rivers, Kogi, Enugu, Imo, Delta, Oyo & Kebbi) and remain active.iv
4.5 Mid-term Lassa fever review meeting conducted on February 15, 2019
4.6 Multi sectoral one health national rapid response team (NCDC, NFELTP, Federal Ministry of Agriculture & Federal of Ministry of Environment) deployed to Edo, Ondo, Bauchi, Ebonyi and Plateau States
4.7 High level advocacy visit by the DG NCDC to Plateau State
4.8 NCDC prepositioned PPEs, Ribavirin (injection and tablets), beds, Tents, body-bags, thermometers, hypochlorite hand sanitizers, IEC materials, guidelines and SOPS distributed across 36 states, FCT and treatment centres
4.9 A National Lassa fever multi-partner, multi-sectoral Emergency Operational Centre (EOC) continues to coordinate the response activities at all levels. State EOCs have also been activated in Edo, Ondo, Plateau and Ebonyi
5.1 In the reporting week, 1104 suspected cases of measles with nine laboratory confirmed and two deaths (CFR, 0.18%) were reported from 34 states compared with 434 suspected cases and four deaths (CFR,0.92%) reported from 35 states during the same period in 2018
5.2 Since the beginning of the year, 3723 suspected measles cases with 305 laboratory confirmed and six deaths (CFR, 0.16%) were reported from 36 states and FCT compared with 1943 suspected cases and 20 deaths (CFR, 1.03 %) from 36 States and FCT, during the same period in 2018
5.3 Response measures include immunization for all vaccine-preventable diseases in some selected/affected wards and LGAs during Supplementary Immunization Activities (SIAs), as well as case management
6 Yellow fever
6.1 In the reporting week 5 (28th January – 3rd February, 2019), no new confirmed case from Nigeria at WHO reference laboratory, Institute Pasteur Dakar (IP Dakar)
6.2 From the onset of this outbreak on September 12, 2017 to date, a total of 4,100 suspected yellow fever cases have been reported from 36 States & FCT. Of the 3,780 samples taken, 274 were presumptive positives in-country
6.3 A total of 95 cases have been confirmed by IP Dakar from 14 states (Kwara, Kogi, Kano, Zamfara, Kebbi, Nasarawa, Niger, Katsina, Edo, Ekiti, Rivers, Anambra, FCT, and Benue States)
6.4 Since the onset of the outbreak, 27 deaths among IP Dakar confirmed cases and 50 deaths among suspected/presumptive positive cases have been recorded. Case Fatality Rates among IP Dakar confirmed cases and presumptive positives are 1.8% and 22. 4% respectively
6.5 Yellow fever reactive vaccination campaigns were conducted in the following States: Edo (13 LGAs), Kebbi (7 LGAs), Niger (5 LGAs), Sokoto (1 LGA) & Katsina (1 LGA)
6.6 A multi-agency national Emergency Operations Centre is coordinating the national response
6.7 Yellow fever vaccination campaigns have been successfully completed in 12 States (Nasarawa, Cross River, Akwa-Ibom, Kogi, Kwara, Zamfara, Sokoto, Kebbi, Niger, FCT, Plateau & Borno) and 57 political wards in 25 LGAs in Borno State. Another campaign to commence in Vandekeiya LGA in Benue State
6.8 The 2018 phase 2b November Preventive Mass Vaccination Campaign (PMVC) was conducted (22nd November – 1st December, 2018) in Sokoto, Kebbi, Niger, FCT, Plateau and some LGAs in Borno States. Target population is 9 months to 44 years (85% of the total population)
6.9 Yellow fever After Action Review (AAR) being planned and is slated for April 2019
7. Update on national Influenza sentinel surveillance, Nigeria week 1 – 7, 2019
7.1 From week 1- 7 2019, a total of 55 samples were recruited, of which 54 were Influenza like-illness (ILI) and one was Severe Acute Respiratory Infection (SARI) .
7.2 A total of 55 samples were received and all samples were processed. Of the processed samples, 54(98.2%) were ILI cases and 1 (1.8%) was Severe Acute Respiratory Infection (SARI).
7.3 Of the 54 processed ILI samples, 4 (7.4%) were positive for Influenza A; 1(1.9%) was positive for Influenza B and 49 (90.7%) were negative.
7.4 The processed SARI sample was negative for both Influenza A and B.
7.5 Of the 54 processed samples, five (9.1%) were positive for Influenza, with four (80.0%) of these positive for Influenza A and one (20.0%) positive for Influenza B.
7.6 The subtypes A seasonal H3, 2009A/H1N1 and A/not subtyped account for four (100.0%), 0 (0.0%) and 0 (0.0%) of the total influenza A positive samples respectively.
7.7 The subtypes B VICTORIA, B Not subtyped and B Yamagata account for 0(0.0%), one(100.0%) and 0(0.0%) of the total influenza B positive samples respectively
7.8 The percentage of influenza positive was highest (75.0%) in week 7, 201
7.9 In the reporting week 1- 7, all samples were processed in the laboratory
FOR MORE INFORMATION CONTACT
Nigeria Centre for Disease Control,
801 Ebitu Ukiwe Street, Jabi, Abuja, Nigeria.